PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising progress across various healthcare and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, additional reputable choice for therapeutic use,